MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Sells 65,411 Shares of The Clorox Company $CLX

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH decreased its position in shares of The Clorox Company (NYSE:CLX) by 98.7% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 841 shares of the company’s stock after selling 65,411 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s holdings in Clorox were worth $101,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Raymond James Financial Inc. lifted its position in Clorox by 15.6% in the 1st quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after buying an additional 36,352 shares during the last quarter. OneDigital Investment Advisors LLC purchased a new position in shares of Clorox during the first quarter worth approximately $247,000. Brown Miller Wealth Management LLC bought a new stake in shares of Clorox in the 1st quarter worth approximately $399,000. Roman Butler Fullerton & Co. bought a new stake in shares of Clorox in the 1st quarter worth approximately $400,000. Finally, Wedge Capital Management L L P NC boosted its stake in shares of Clorox by 33.5% in the 1st quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company’s stock valued at $4,198,000 after purchasing an additional 7,159 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.57% of the stock is currently owned by insiders.

Clorox Trading Down 0.3%

NYSE CLX opened at $122.76 on Friday. The stock has a market cap of $15.01 billion, a P/E ratio of 18.83, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52. The Clorox Company has a fifty-two week low of $116.53 and a fifty-two week high of $171.37. The stock has a 50 day simple moving average of $123.61 and a two-hundred day simple moving average of $130.63. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm’s revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the firm posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a dividend yield of 4.0%. Clorox’s payout ratio is currently 76.07%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on CLX. Jefferies Financial Group lowered their price target on shares of Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a research note on Thursday, June 26th. Citigroup reiterated a “neutral” rating and issued a $135.00 price objective (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. JPMorgan Chase & Co. boosted their target price on Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a research note on Monday, September 8th. Wells Fargo & Company dropped their target price on Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a report on Thursday. Finally, Morgan Stanley decreased their price target on Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a research note on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and an average target price of $141.73.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.